-+ 0.00%
-+ 0.00%
-+ 0.00%

Accenture Stock And 2 Dividend Shares Yielding More Than 3%

Simply Wall St·07/26/2026 04:39:32
Listen to the news

Dividend Powerhouses offering 3%+ yields can be especially appealing when headlines are dominated by energy price swings, central bank decisions and uneven growth signals across major economies. Reliable dividend income that is well covered, growing and relatively stable gives you a way to stay invested while markets react to Middle East tensions, shifting rate expectations and mixed inflation data. This article focuses on companies that fit that profile and come from the Dividend Powerhouses screener, and will highlight several stocks that currently meet its rules based solely on the criteria you see here.

Accenture (ACN)

Overview: Accenture is a global consulting and technology services company that helps large businesses and public sector clients design, build and run their operations, from cloud, data and AI systems to finance, supply chain and customer support processes.

Operations: Accenture generates most of its revenue from Products at about US$22.3b, followed by Health & Public Service at about US$14.9b, Financial Services at about US$13.8b, Communications, Media & Technology at about US$12.4b, and Resources at about US$9.8b.

Market Cap: US$90.0b

Accenture stands out for income investors because it pairs a 4.44% dividend yield with fundamentals such as a 23.7% ROE and a P/E of 11.5x relative to its sector. The company is involved in AI, cybersecurity and digital transformation projects, supported by recent alliances with Google Cloud and ServiceNow and a plan to deploy about US$9b on acquisitions. The stock has recently lagged the broader IT sector, reflecting concerns about slower revenue growth, reliance on external funding and a relatively new executive team. For investors who value dividends, established client relationships and the company’s role in AI-related projects, there is more to Accenture than the headline numbers suggest.

Accenture’s 4.44% yield, 23.7% ROE and exposure to AI projects could be masking a much bigger story about quality and valuation. Get the full picture in the DCF valuation analysis for Accenture

ACN Discounted Cash Flow as at Jul 2026
ACN Discounted Cash Flow as at Jul 2026

Medtronic (MDT)

Overview: Medtronic is a global medical device company that supplies hospitals and clinicians with products such as heart pacemakers and defibrillators, spinal and brain implants, surgical tools, robotic surgery systems, and diabetes management devices.

Operations: Medtronic generates most of its revenue from Cardiovascular at about US$14.0b, followed by Neuroscience at about US$10.3b, Medical Surgical at about US$8.8b, and Other at about US$3.2b, with sales split fairly evenly between the United States at about US$18.1b and the rest of the world at about US$18.1b.

Market Cap: US$106.5b

Income investors may want to look closely at Medtronic because it combines a roughly 3.41% dividend yield with a long track record of increases, including its 49th consecutive raise. The company is also pushing into areas such as AI-enabled surgery, robotics, and advanced cardiac and neuromodulation devices. Analysts expect earnings and revenue growth; however, margins have recently come under pressure and several product lines, including parts of Diabetes and MedSurg, are still underperforming, with product recalls and execution risks around new launches adding extra uncertainty. The stock trades below some peer valuation multiples. A key consideration is how this pipeline, restructuring, and the Diabetes spin-off could reshape Medtronic’s earnings power and dividend profile over time.

Medtronic’s reshaping story, from AI-enabled surgery to a Diabetes spin-off, could be more than the market is pricing in. See how these moving parts fit together in the analysis report for Medtronic

NYSE:MDT Earnings & Revenue Growth as at Jul 2026
NYSE:MDT Earnings & Revenue Growth as at Jul 2026

Canadian Natural Resources (TSX:CNQ)

Overview: Canadian Natural Resources is a Calgary based oil and gas producer that acquires, develops and operates assets across Western Canada, the North Sea and Offshore Africa, supplying crude oil, natural gas and natural gas liquids to global markets.

Operations: Canadian Natural Resources generates most of its revenue from North American exploration and production at about CA$19.1b and Oil Sands Mining and Upgrading at about CA$17.4b, with smaller contributions from Midstream and Refining at about CA$0.8b and the North Sea at about CA$0.2b.

Market Cap: CA$136.2b

Canadian Natural Resources stands out in the Dividend Powerhouses screener because it couples a roughly 3.8% yield and a long dividend growth track record with sizeable free cash flow that is supporting share buybacks and ongoing production investment. Recent acquisitions, cost efficiencies and higher utilization in its oil sands operations are improving cash generation and giving the company more flexibility to return capital, even as analysts factor in slower revenue and earnings ahead. At the same time, reliance on higher cost oil sands, external funding, and exposure to carbon and pipeline regulations could pressure margins if conditions turn less favorable. For investors weighing these trade offs, the gap between current pricing and cash flow based value estimates is a key piece of the Canadian Natural Resources story that deserves a closer look.

Canadian Natural Resources’ cash flow, dividend growth and share buybacks hint at a valuation story many investors may be overlooking, and the real tension between rewards and risks is spelled out in the 4 key rewards and 2 important warning signs (1 is major!)

CNQ Discounted Cash Flow as at Jul 2026
CNQ Discounted Cash Flow as at Jul 2026

The three dividend stocks in this article are just a starting point, and the full Dividend Powerhouses screen has surfaced 1,899 more companies with yields above 3% and equally compelling income stories in the Dividend Powerhouses (3%+ Yield) screener. Use Simply Wall St to identify, filter and analyze the specific catalysts and dividend narratives that matter most to you so you can focus on the highest conviction opportunities.

Take Control of Your Investment Journey

If Medtronic or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before Others?

Breakout ideas rarely stay quiet for long, and the fastest moves often happen while most investors are still watching yesterday’s stories. Review these fresh lists before the momentum is widely noticed.

  • Spot high potential turnarounds early by reviewing the curated 19 high quality undiscovered gems that are still under the radar for now.
  • Review structural demand in critical materials with a focused look at the 8 top copper producer stocks supplying essential infrastructure and electrification projects worldwide.
  • Explore income and resilience by screening through the hand picked 9 dividend fortresses before more yield-focused investors review the same names.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.